Microtubule assembly dynamics: An attractive target for anticancer drugs

Microtubules, composed of αβ tubulin dimers, are dynamic polymers of eukaryotic cells. They play important roles in various cellular functions including mitosis. Microtubules exhibit differential dynamic behaviors during different phases of the cell cycle. Inhibition of the microtubule assembly dynamics causes cell cycle arrest leading to apoptosis; thus, qualifying them as important drug targets for treating several diseases including cancer, neuronal, fungal, and parasitic diseases. Although several microtubule‐targeted drugs are successfully being used in cancer chemotherapy, the development of resistance against these drugs and their inherent toxicities warrant the development of new agents with improved efficacy. Several antimicrotubule agents are currently being evaluated for their possible uses in cancer chemotherapy. Benomyl, griseofulvin, and sulfonamides have been used as antifungal and antibacterial drugs. Recent reports have shown that these drugs have potent antitumor potential. These agents are shown to inhibit proliferation of different types of tumor cells and induce apoptosis by targeting microtubule assembly dynamics. However, unlike vincas and taxanes, which inhibit cancer cell proliferation in nanomolar concentration range, these agents act in micromolar range and are considered to have limited toxicities. Here, we suggest that these drugs may have a significant use in cancer chemotherapy when used in combination with other anticancer drugs. © 2008 IUBMB IUBMB Life, 60(6): 368–375, 2008

[1]  M. Gore,et al.  Phase II study of E7070 in patients with metastatic melanoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Malawista,et al.  Vinblastine and Griseofulvin Reversibly Disrupt the Living Mitotic Spindle , 1968, Science.

[3]  Kenneth H. Downing,et al.  Structure of the αβ tubulin dimer by electron crystallography , 1998, Nature.

[4]  C. Sunkel,et al.  Different spindle checkpoint proteins monitor microtubule attachment and tension at kinetochores in Drosophila cells , 2004, Journal of Cell Science.

[5]  M. Sumura,et al.  Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer. , 2007, European urology.

[6]  C. Walczak,et al.  Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. , 2004, Molecular cell.

[7]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[8]  NF‐κB pathway is involved in griseofulvin‐induced G2/M arrest and apoptosis in HL‐60 cells , 2007 .

[9]  N. Waters,et al.  Structure-Function Relationships of the Yeast , 1995 .

[10]  K. Rathinasamy,et al.  Suppression of microtubule dynamics by benomyl decreases tension across kinetochore pairs and induces apoptosis in cancer cells , 2006, The FEBS journal.

[11]  P. Fine,et al.  Toxic acute tubular necrosis following treatment with zoledronate (Zometa). , 2003, Kidney international.

[12]  P. Friedman,et al.  Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin. , 1978, Biochimica et biophysica acta.

[13]  Austin J. Peck,et al.  Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. , 2004, Biochemistry.

[14]  G. Hudes,et al.  Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. , 1995, Seminars in oncology.

[15]  J. Kilmartin.  Purification of yeast tubulin by self-assembly in vitro. , 1981, Biochemistry.

[16]  D. Panda,et al.  Suppression of Microtubule Dynamics by LY290181 , 1997, The Journal of Biological Chemistry.

[17]  A. Yoshimura,et al.  Phase I study of E7010 , 1998, Cancer Chemotherapy and Pharmacology.

[18]  A. Fojo,et al.  Microtubule targeting agents: basic mechanisms of multidrug resistance (MDR). , 2005, Seminars in oncology.

[19]  A. Walpole,et al.  Some Cytological Effects of Griseofulvin , 1958, Nature.

[20]  S. Litwin,et al.  Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Bensch,et al.  Antimitotic Action of Griseofulvin does not Involve Disruption of Microtubules , 1973, Nature.

[22]  T. Mitchison,et al.  Microtubule polymerization dynamics. , 1997, Annual review of cell and developmental biology.

[23]  L. C. Davidse,et al.  Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans , 1977, The Journal of cell biology.

[24]  M. Kirschner,et al.  Dynamic instability of microtubule growth , 1984, Nature.

[25]  K. Gull,et al.  Griseofulvin inhibits Fungal Mitosis , 1973, Nature.

[26]  R. Margolis,et al.  Opposite end assembly and disassembly of microtubules at steady state in vitro , 1978, Cell.

[27]  T. Owa,et al.  Sulfonamide drugs binding to the colchicine site of tubulin: thermodynamic analysis of the drug-tubulin interactions by isothermal titration calorimetry. , 2005, Journal of medicinal chemistry.

[28]  D. Zaharevitz,et al.  A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach. , 2005, Journal of medicinal chemistry.

[29]  M. Steinmetz,et al.  Structural basis for the regulation of tubulin by vinblastine , 2005, Nature.

[30]  T. Fojo,et al.  Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin. , 2004, Molecular cancer therapeutics.

[31]  D. Botstein,et al.  Structure-function relationships in yeast tubulins. , 2000, Molecular biology of the cell.

[32]  B. Oakley,et al.  Amino acid alterations in the benA (beta-tubulin) gene of Aspergillus nidulans that confer benomyl resistance. , 1992, Cell motility and the cytoskeleton.

[33]  K. Weber,et al.  Interaction of griseofulvin with microtubules, microtubule protein and tubulin. , 1977, Journal of molecular biology.

[34]  B. Oakley,et al.  Identification of an amino acid substitution in the benA, beta-tubulin gene of Aspergillus nidulans that confers thiabendazole resistance and benomyl supersensitivity. , 1990, Cell motility and the cytoskeleton.

[35]  T. Owa,et al.  Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation. , 2006, Biochemistry.

[36]  Y. Ho,et al.  Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice , 2002, Molecular carcinogenesis.

[37]  B. Bhattacharyya,et al.  anti-Mitotic Activity of Colchicine and the Structural Basis for Its Interaction with Tubulin , 2008 .

[38]  C. Rieder,et al.  Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle , 1994, The Journal of cell biology.

[39]  E. Salmon,et al.  Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies , 1988, The Journal of cell biology.

[40]  J. Scholey,et al.  Spindle mechanics and dynamics during mitosis in Drosophila. , 2004, Trends in cell biology.

[41]  K. Weber,et al.  Griseofulvin interacts with microtubules both in vivo and in vitro. , 1976, Journal of molecular biology.

[42]  B. Bhattacharyya,et al.  Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin , 2008, Medicinal research reviews.

[43]  E. Nogales,et al.  Structure of tubulin at 6.5 Å and location of the taxol-binding site , 1995, Nature.

[44]  S. Ciappellano,et al.  Study Design of a TotalReference Diet for a Population inNorthern Italy , 1998, Annals of Nutrition and Metabolism.

[45]  R. Safirstein,et al.  Cisplatin nephrotoxicity: insights into mechanism. , 1987, International journal of andrology.

[46]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[47]  F. Uhlmann,et al.  Stabilization of microtubule dynamics at anaphase onset promotes chromosome segregation , 2005, Nature.

[48]  K. Rathinasamy,et al.  Kinetic suppression of microtubule dynamic instability by griseofulvin: implications for its possible use in the treatment of cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Krämer,et al.  Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. , 2007, Cancer research.

[50]  T. Owa,et al.  A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors. , 2000, Bioorganic & medicinal chemistry letters.

[51]  D. Panda,et al.  Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Salmon,et al.  Oscillatory movements of monooriented chromosomes and their position relative to the spindle pole result from the ejection properties of the aster and half-spindle , 1986, The Journal of cell biology.

[53]  D. Panda,et al.  Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Friedlander,et al.  New treatments for tinea capitis , 2004, Current opinion in infectious diseases.